Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin-Reference-Cited by-同舟云学术

Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin

Published:2018-07-05 Issue:10 Volume:73 Page:2762-2769
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Müller Laura¹,Murgia Xabier²³,Siebenbürger Lorenz⁴,Börger Carsten⁴,Schwarzkopf Konrad⁵,Sewald Katherina¹,Häussler Susanne⁶⁷,Braun Armin¹,Lehr Claus-Michael²⁴⁸,Hittinger Marius⁴,Wronski Sabine¹

Affiliation:

1. Fraunhofer Institute for Toxicology and Experimental Medicine (Fraunhofer ITEM), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Centre for Lung Research (DZL), Member of the REBIRTH Cluster of Excellence, Nikolai-Fuchs-Straße 1, Hannover, Germany

2. Helmholtz Institute for Pharmaceutical Research (HIPS), Helmholtz Centre for Infection Research, Universitätscampus E8.1, Saarbrücken, Germany

3. Korea Institute of Science and Technology, KIST Europe, Campus E7.1, Saarbrücken, Germany

4. PharmBioTec GmbH, Science Park 1, Saarbrücken, Germany

5. Department of Anaesthesia and Intensive Care, Klinikum Saarbrücken, Winterberg 1, Saarbrücken, Germany

6. Helmholtz Institute for Infection Research, Inhoffenstraße 7, Braunschweig, Germany

7. TWINCORE, Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Straße 7, Hannover, Germany

8. Department of Pharmacy, Saarland University, Campus, Saarbrücken, Germany

Funder

Fraunhofer Institute for Toxicology

Helmholtz Institute for Pharmaceutical Research and PharmBioTec GmbH

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/10/2762/25770371/dky241.pdf

Reference52 articles.

1. Mucin structure, aggregation, physiological functions and biomedical applications;Bansil;Curr Opin Colloid Interface Sci,2006

2. Mucus clearance as a primary innate defense mechanism for mammalian airways;Knowles;J Clin Invest,2002

3. Clinical issues of mucus accumulation in COPD;Ramos;Int J Chron Obstruct Pulmon Dis,2014

4. Ex vivo sputum analysis reveals impairment of protease-dependent mucus degradation by plasma proteins in acute asthma;Innes;Am J Respir Crit Care Med,2009

5. Cystic fibrosis sputum: a barrier to the transport of nanospheres;Sanders;Am J Respir Crit Care Med,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response;Frontiers in Immunology;2024-06-28

2. Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection;mBio;2024-06-12

3. State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives;Pharmaceutics;2024-03-01

4. Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms;PLOS ONE;2024-02-23

5. Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment;Journal of Controlled Release;2024-01